Speaker

Weihao Xu

Founder & Chief Executive Officer, Kali Therapeutics

Weihao Xu, Founder & Chief Executive Officer at Kali Therapeutics, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Scientific, Operational & Economic Realities for Immune-Modulating Therapies: What Have we Learnt so Far?”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Oncology & Cancer Research

Past appearances

Oncology & Immunology Innovation Partnering & Licensing Summit
9–10 Sept 2026Boston, United States of America
- PanelScientific, Operational & Economic Realities for Immune-Modulating Therapies: What Have we Learnt so Far?With Frank Brennan, Kevin White, Shawn Davis, John Gerecitano
- PanelWhat can be Improved Upon for Existing Drugs?With Frank Brennan, William Ho, Ramesh Singh

More speakers at Oncology & Immunology Innovation Partnering & Licensing Summit

Carla Bauer
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Akihiro Furukawa
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Adam Gilbert
Science Partner, Flagship Pioneering
Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Jason Kantor
Chief Business Officer, Nurix Therapeutics, Inc.
Nikhil Mutyal
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

See all 52 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Weihao Xu, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].